NAY-doe-lole
Therapeutic Classification: antianginals, antihypertensives
Pharmacologic Classification: beta blockers
REMS
Absorption: 30% absorbed after oral administration.
Distribution: Minimal penetration of the CNS.
Half-Life: 10–24 hr (↑ in renal impairment).
Contraindicated in:
Use Cautiously in:
CV: ARRHYTHMIAS, BRADYCARDIA, HF, orthostatic hypotension, peripheral vasoconstriction, PULMONARY EDEMA
Derm: itching, rash
EENT: blurred vision, dry eye, nasal stuffiness
Endo: hyperglycemia, hypoglycemia
GI: constipation, diarrhea, nausea
GU: erectile dysfunction, ↓libido
MS: arthralgia, back pain, muscle cramps
Neuro: fatigue, weakness, anxiety, depression, dizziness, drowsiness, insomnia, memory loss, mental status changes, nightmares, paresthesia
Resp: bronchospasm, wheezing
Misc: drug-induced lupus syndrome
Drug-drug:
Renal Impairment
Lab Test Considerations:
Toxicity and Overdose:
NDC Code